Went Gregory T

Adamas Pharmaceuticals Inc

Chief Executive Officer, Director

Avg. Two Year Performance

(73%) Avg. Purchase Return (32%) Compound

27% Avg. Sale Return 12% Compound

Holdings: 431.78K shares

Last Three Months: 05-Feb-24 -- 04-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drugs - Generic

Drugs

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions